Skip to content

Electrode-based Sensor for Non-invasive Fetal Heart Rate and EMG Monitoring With Improved Reliability

Electrode-based Sensor for Non-invasive Fetal Heart Rate and EMG Monitoring With Improved Reliability

Status
Completed
Phases
Early Phase 1
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01400880
Enrollment
103
Registered
2011-07-22
Start date
2011-07-01
Completion date
2014-04-01
Last updated
2026-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pregnancy

Keywords

Maternal Fetal Monitoring

Brief summary

The specific goal of the proposed research is to develop a reliable, non-invasive fetal and maternal heart rate and contraction monitor that is unaffected by obesity and requires less nursing intervention than the tocodynamometer and Doppler ultrasound.

Detailed description

The majority of obstetric deliveries in the US undergo electronic monitoring and continuous uterine activity and fetal heart rate (FHR) monitoring is the standard of care. Typically, external transducers are employed, the reliability of which depends on their proper positioning, which may be disturbed by patient or fetal movement. The tocodynamometer (strain gauge, toco for short) provides frequency and timing of contractions, but requires transmission of tension from the uterus to the sensor. Fetal heart rate is acquired with an external Doppler ultrasound transducer. The reliability of this monitor depends on the ability to obtain a window to the fetal heart. In some patients, particularly the obese, the toco and ultrasound may fail to monitor consistently. In others both transducers require frequent repositioning by the nursing staff, and the Doppler may erroneously report maternal heart rate instead of fetal. The alternative uterine activity monitor is an intrauterine pressure catheter (IUPC), which is placed through the cervical os in the adequately dilated patient with ruptured membranes. While this monitor usually provides a more reliable signal than the toco, as well as quantitative information regarding intrauterine pressure, it is invasive and there is an increased risk of infection. The alternative FHR monitor is via fetal scalp electrode (FSE), which is applied transvaginally to the fetal presenting part, also requiring adequate cervical dilation and ruptured membranes. While the FSE usually provides a more reliable signal, it is similarly invasive and increases risk of infection.

Interventions

DEVICEElectrode-based Sensor

Electrode-based Sensor for Non-invasive Fetal Heart Rate and EMG Monitoring With Improved Reliability

Sponsors

Convergent Engineering, Inc.
Lead SponsorINDUSTRY

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
DEVICE_FEASIBILITY
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 50 Years
Healthy volunteers
Yes

Inclusion criteria

* Women between the ages of 18 and 50 years old * \>/= 34 weeks gestation * Single viable fetus in cephalic presentation

Exclusion criteria

* Bleeding or uterine scarring

Design outcomes

Primary

MeasureTime frameDescription
Comparison of Electrode Sensor and TOCO Detection of Contraction Events, as Compared to IUPCStage I and II LaborContraction timing as measured by the electrode sensor and contraction timing as measure by the TOCO, both compared to the contraction timing as measured by the IUPC gold standard. The contraction timing values of the electrode sensor and TOCO were then compared.

Countries

United States

Contacts

PRINCIPAL_INVESTIGATORAnthony Gregg, PhD

University of Florida

Participant flow

Participants by arm

ArmCount
Primary
Pregnant women between the ages of 18-50 with a single viable fetus in cephalic presentation
101
Total101

Baseline characteristics

CharacteristicPrimary
Age, Categorical
<=18 years
0 Participants
Age, Categorical
>=65 years
0 Participants
Age, Categorical
Between 18 and 65 years
101 Participants
Sex/Gender, Customized
Pregnant Women
101 participants

Adverse events

Event typeEG000
affected / at risk
other
Total, other adverse events
15 / 103
serious
Total, serious adverse events
0 / 103

Outcome results

Primary

Comparison of Electrode Sensor and TOCO Detection of Contraction Events, as Compared to IUPC

Contraction timing as measured by the electrode sensor and contraction timing as measure by the TOCO, both compared to the contraction timing as measured by the IUPC gold standard. The contraction timing values of the electrode sensor and TOCO were then compared.

Time frame: Stage I and II Labor

Population: Pregnant women between the ages of 18-50 with a single viable fetus in stages I and/or II of labor

ArmMeasureGroupValue (MEAN)Dispersion
Electrode Sensor, TOCO and IUPCComparison of Electrode Sensor and TOCO Detection of Contraction Events, as Compared to IUPCTOCO patient group2.98 secondsStandard Deviation 3.28
Electrode Sensor, TOCO and IUPCComparison of Electrode Sensor and TOCO Detection of Contraction Events, as Compared to IUPCElectrode Sensor patient group3.95 secondsStandard Deviation 2.65
Comparison: All subjects were monitored with the electrode sensor, TOCO and IUPC. Measurements were taken with the electrode sensor vs. IUPC and were also taken with TOCO vs. IUPC and those measurements were compared to each other. These results are for TOCO and IUPC. Agreement between TOCO and IUPC. Null hypothesis: the mean peak difference between TOCO and IUPC is equal to 0. Alternative hypothesis: the mean peak difference is not equal to 0.95% CI: [1.7, 4.27]
Comparison: All subjects were monitored with the electrode sensor, TOCO and IUPC. Measurements were taken with the electrode sensor vs. IUPC and were also taken with TOCO vs. IUPC and those measurements were compared to each other. These results are for the electrode sensor and IUPC. Agreement between electrode sensor and IUPC. Null hypothesis: the mean peak difference between TOCO and IUPC is equal to 0. Alternative hypothesis: the mean peak difference is not equal to 0.95% CI: [2.98, 4.92]

Source: ClinicalTrials.gov · Data processed: Apr 8, 2026